Form 8-K - Current report:
SEC Accession No. 0001104659-20-077460
Filing Date
2020-06-26
Accepted
2020-06-26 16:13:56
Documents
4
Period of Report
2020-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023488d1_8k.htm 8-K 24407
2 EXHIBIT 10.1 tm2023488d1_ex10-1.htm EX-10.1 87310
3 EXHIBIT 99.1 tm2023488d1_ex99-1.htm EX-99.1 15148
4 GRAPHIC logo.jpg GRAPHIC 1982
  Complete submission text file 0001104659-20-077460.txt   131157
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 20994281
SIC: 2836 Biological Products, (No Diagnostic Substances)